These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 25677767)

  • 1. Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.
    Lohman RJ; Harrison RS; Ruiz-Gómez G; Hoang HN; Shepherd NE; Chow S; Hill TA; Madala PK; Fairlie DP
    Vitam Horm; 2015; 97():1-55. PubMed ID: 25677767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of small peptides as NOP and opioid receptors' ligands: view on current developments.
    Naydenova E; Todorov P; Zamfirova R
    Vitam Horm; 2015; 97():123-46. PubMed ID: 25677770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nociceptin, endogenous opioid peptide. Preface.
    Litwack G
    Vitam Horm; 2015; 97():xv-xvi. PubMed ID: 25677779
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic.
    Thompson AA; Liu W; Chun E; Katritch V; Wu H; Vardy E; Huang XP; Trapella C; Guerrini R; Calo G; Roth BL; Cherezov V; Stevens RC
    Nature; 2012 May; 485(7398):395-9. PubMed ID: 22596163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids.
    Butour JL; Moisand C; Mazarguil H; Mollereau C; Meunier JC
    Eur J Pharmacol; 1997 Feb; 321(1):97-103. PubMed ID: 9083791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of Nociceptin/Orphanin FQ Peptide Analogs for Drug Development.
    Wtorek K; Janecka A
    Chem Biodivers; 2021 Jan; 18(1):e2000871. PubMed ID: 33351271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nociceptin (ORL-1) and mu-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization.
    Hawes BE; Fried S; Yao X; Weig B; Graziano MP
    J Neurochem; 1998 Sep; 71(3):1024-33. PubMed ID: 9721727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain regulation by nocistatin-targeting molecules: G protein-coupled-receptor and nocistatin-interacting protein.
    Okuda-Ashitaka E; Ito S
    Vitam Horm; 2015; 97():147-65. PubMed ID: 25677771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of the first small-molecule opioid pan antagonist with nanomolar affinity at mu, delta, kappa, and nociceptin opioid receptors.
    Zaveri NT; Journigan VB; Polgar WE
    ACS Chem Neurosci; 2015 Apr; 6(4):646-57. PubMed ID: 25635572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel helix-constrained nociceptin derivatives are potent agonists and antagonists of ERK phosphorylation and thermal analgesia in mice.
    Harrison RS; Ruiz-Gómez G; Hill TA; Chow SY; Shepherd NE; Lohman RJ; Abbenante G; Hoang HN; Fairlie DP
    J Med Chem; 2010 Dec; 53(23):8400-8. PubMed ID: 21067234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of the nociceptin receptor does not affect acute or chronic nociception in mice.
    Bertorelli R; Bastia E; Citterio F; Corradini L; Forlani A; Ongini E
    Peptides; 2002 Sep; 23(9):1589-96. PubMed ID: 12217419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.
    Lutfy K; Eitan S; Bryant CD; Yang YC; Saliminejad N; Walwyn W; Kieffer BL; Takeshima H; Carroll FI; Maidment NT; Evans CJ
    J Neurosci; 2003 Nov; 23(32):10331-7. PubMed ID: 14614092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin.
    Sbrenna S; Marti M; Morari M; Calo' G; Guerrini R; Beani L; Bianchi C
    Br J Pharmacol; 2000 May; 130(2):425-33. PubMed ID: 10807682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic interaction between the agonism of cebranopadol at nociceptin/orphanin FQ and classical opioid receptors in the rat spinal nerve ligation model.
    Christoph T; Raffa R; De Vry J; Schröder W
    Pharmacol Res Perspect; 2018 Dec; 6(6):e00444. PubMed ID: 30519474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selective small molecule NOP (ORL-1 receptor) partial agonist for the treatment of anxiety.
    Ross TM; Battista K; Bignan GC; Brenneman DE; Connolly PJ; Liu J; Middleton SA; Orsini M; Reitz AB; Rosenthal DI; Scott MK; Vaidya AH
    Bioorg Med Chem Lett; 2015 Feb; 25(3):602-6. PubMed ID: 25556095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxyl terminal peptides derived from prepro-orphanin FQ/nociceptin (ppOFQ/N) are produced in the hypothalamus and possess analgesic bioactivities.
    Mathis JP; Rossi GC; Pellegrino MJ; Jimenez C; Pasternak GW; Allen RG
    Brain Res; 2001 Mar; 895(1-2):89-94. PubMed ID: 11259764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics and evolution of vertebrate nociceptin and opioid receptors.
    Stevens CW
    Vitam Horm; 2015; 97():57-94. PubMed ID: 25677768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain.
    Sukhtankar DD; Zaveri NT; Husbands SM; Ko MC
    J Pharmacol Exp Ther; 2013 Jul; 346(1):11-22. PubMed ID: 23652222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu-opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptor activation both contribute to the discriminative stimulus properties of cebranopadol in the rat.
    Tzschentke TM; Rutten K
    Neuropharmacology; 2018 Feb; 129():100-108. PubMed ID: 29155273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.